A novel approach to pH-Responsive targeted cancer Therapy: Inhibition of FaDu cancer cell proliferation with a pH low insertion Peptide-Conjugated DGAT1 inhibitor
Article in International Journal of Pharmaceutics (April 2024)
The most recent citing publications are shown below. View all 86 publications that cite this research output on Dimensions.
Article in International Journal of Pharmaceutics (April 2024)
Article in Journal of Drug Targeting (February 2024)
Article in Trends in Endocrinology and Metabolism (December 2023)